Page 187 of 286 · 8,574 total

patent

Samsung Electronics Co., Ltd. et al. v.Optimum Imaging Technologies LLC

· IPR2025-00462

Samsung has filed an IPR petition seeking to invalidate ten claims of Optimum Imaging’s ’339 patent covering in‑camera aberration correction, arguing obviousness over multiple prior‑art references and that discretionary denial is unwarranted.

patent

LifeVac, LLC v.DCStar Inc.

· IPR2025-00454

LifeVac has filed an IPR petition seeking to invalidate DCStar’s 11,478,575 patent covering an anti‑choking suction device. The petition relies on Chinese reference Zhongnan and Korean reference Yuchang to argue obviousness of all 17 claims and urges the Board not to deny institution under §§ 314(a) and 325(d).

patent

Samsung Electronics Co., Ltd. et al. v.Cerence Operating Company

· IPR2025-00458

Samsung has filed an IPR petition seeking cancellation of all 20 claims of Cerence’s ’671 patent, arguing they are obvious over existing text‑to‑speech technologies. The petition also argues that discretionary factors favor instituting the review.

patent

NeoGenomics Laboratories, Inc. v.Natera, Inc.

· IPR2025-00455

NeoGenomics seeks IPR of Natera’s ’596 patent covering liquid‑biopsy methods, arguing the claims are obvious over multiple pre‑2015 publications and that the examiner erred. The petition also disputes any discretionary denial, urging the Board to institute review and cancel the claims.

patent

Celltrion, Inc. v.Regeneron Pharmaceuticals, Inc.

· IPR2025-00456

Celltrion seeks IPR institution to invalidate all 50 claims of Regeneron’s US 11,084,865, arguing anticipation by US432 and lack of written description for glycosylation and stability limits.

patent

Eunsung Global Corp. v.HydraFacial LLC et al.

· IPR2025-00453

Eunsung Global Corp. petitions the PTAB to cancel HydraFacial's 11,446,477 skin‑treatment patent, alleging obviousness over several prior‑art references.

patent

Eunsung Global Corp. v.HydraFacial LLC et al.

· IPR2025-00452

Eunsung Global Corp. has filed an IPR petition seeking cancellation of all twenty claims of HydraFacial’s ’607 skin‑treatment patent, arguing obviousness over a suite of prior‑art microdermabrasion references.

patent

SAMSUNG ELECTRONICS CO., LTD. et al. v.Vasu Holdings, LLC

· IPR2025-00448

Samsung Electronics has filed a petition for inter partes review challenging Vasu Holdings' patent covering Wi‑Fi/cellular handover. The petition alleges obviousness over multiple prior‑art references and asks the PTAB to institute the review.

patent

SAMSUNG ELECTRONICS CO., LTD. et al. v.Vasu Holdings, LLC

· IPR2025-00446

Samsung Electronics has filed an IPR petition challenging Vasu Holdings’ 8,886,181 patent covering seamless Wi‑Fi‑to‑cellular handover. The petition alleges obviousness over multiple prior‑art references and argues that discretionary denial does not apply.

patent

SAMSUNG ELECTRONICS CO., LTD. et al. v.Vasu Holdings, LLC

· IPR2025-00449

Samsung has filed an IPR petition challenging Vasu Holdings’ ’281 patent covering wireless handover. The challenger argues the claims are obvious over multiple prior‑art references and seeks institution of the review.

patent

Eunsung Global Corp. v.HydraFacial LLC et al.

· IPR2025-00445

Eunsung Global Corp. has filed an IPR petition seeking cancellation of all 17 claims of HydraFacial's microdermabrasion console patent, alleging obviousness over multiple prior‑art references. The petition argues the examiner never considered the cited combinations and that discretionary denial is unwarranted.

patent

LG Electronics, Inc. et al. v.Maxell, LTD.

· IPR2025-00444

LG Electronics petitions the PTAB to invalidate Maxell’s ’729 electric‑camera patent, arguing that all four claims are obvious over prior‑art cameras. The petition seeks institution of the IPR and cites favorable discretionary‑denial factors.

patent

Shenzhen Tuozhu Technology Co., Ltd. et al. v.Stratasys, Inc. et al.

· IPR2025-00438

Shenzhen Tuozhu Technology has filed an IPR petition challenging Stratasys’s 3‑D‑printing patent (US 10,569,466), asserting that the claims are obvious over multiple prior‑art references. The petition argues that the Board should institute the review and reject discretionary denial arguments.

patent

Koki Holdings America Ltd. et al. v.Kyocera Senco Industrial Tools, Inc.

· IPR2025-00264

Koki Holdings has filed an IPR petition challenging all 15 claims of Kyocera Senco’s 2023 gas‑spring nailer patent, asserting obviousness over several older patents and arguing that the “lifter” term is means‑plus‑function.

patent

Cambridge Industries USA Inc. et al. v.Applied Optoelectronics, Inc.

· IPR2025-00437

Cambridge Industries has filed an IPR petition seeking cancellation of 19 claims of Applied Optoelectronics’ optical isolator array patent, arguing anticipation by a Chinese patent and obviousness over that patent combined with a U.S. reference. The petition also argues against discretionary denial under §§ 314(a) and 325(d).

patent

Cambridge Industries USA Inc. et al. v.Applied Optoelectronics, Inc.

· IPR2025-00436

Cambridge Industries has filed an IPR petition challenging all 17 claims of Applied Optoelectronics’ 10,313,024 optical‑module patent, asserting anticipation by two prior‑art references and urging the Board to institute review despite discretionary denial arguments.

patent

Zhuhai CosMX Battery Co., Ltd. v.Ningde Amperex Technology Ltd.

· IPR2025-00431

Zhuhai CosMX Battery petitions the PTAB to invalidate claims 1‑7, 12 and 14‑17 of Ningde Amperex’s ’131 lithium‑ion battery patent, asserting obviousness over multiple foreign and U.S. references.

patent

Cambridge Industries USA Inc. et al. v.Applied Optoelectronics, Inc.

· IPR2025-00434

Cambridge Industries has filed an IPR petition seeking cancellation of claims 1‑7 of Applied Optoelectronics’ 10,379,301 patent, arguing that the claims are anticipated by prior‑art references Shen and Soldano. The petition stresses that these references were not used during prosecution and requests the Board to institute review.

patent

Samsung Electronics Co., Ltd et al. v.HEADWATER PARTNERS II LLC

· IPR2025-00426

Samsung has filed an IPR petition challenging all 34 claims of Headwater’s ’868 patent, arguing that the claims are obvious over the Jarvinen and Fox publications. The petition seeks institution of review and argues against discretionary denial.

patent

Nokia of America Corp. v.Adaptive Spectrum and Signal Alignment, Inc.

· IPR2025-00428

Nokia has filed an IPR petition seeking cancellation of all 20 claims of Adaptive Spectrum’s DSL‑crosstalk patent, arguing that the invention is obvious over three prior‑art references that were never considered during prosecution.

patent

PacifiCorp et al. v.MES, Inc.

· IPR2025-00425

PacifiCorp and affiliated utilities have filed a petition to invalidate MES’s ’225 mercury‑removal patent. The petition alleges lack of written‑description support, obviousness over prior art, and anticipation, and urges the PTAB not to deny institution.

patent

PacifiCorp et al. v.MES, Inc.

· IPR2025-00424

PacifiCorp and affiliated utilities have filed an IPR petition seeking to invalidate MES’s 10,589,225 patent covering mercury‑removal methods in coal‑fired power plants. The petition argues obviousness over multiple prior‑art combinations and anticipation by the Downs‑Boiler reference, and requests that the Board not deny institution under §§314(a) and 325(d).

patent

SAP America, Inc. et al. v.Valtrus Innovations Ltd.

· IPR2025-00417

SAP America petitions the PTAB to institute an IPR against Valtrus’s ’409 patent, asserting that all 17 claims are obvious over Khare and Kirkman. The petition also argues that discretionary denial is unwarranted.

patent

SAP America, Inc. et al. v.Valtrus Innovations Ltd.

· IPR2025-00416

SAP America has filed an IPR petition seeking to invalidate 25 claims of Valtrus Innovations' 7,313,575 patent, arguing that the Chen IBM Redbooks publication makes those claims obvious under 35 U.S.C. §103. The petition also argues against discretionary denial under §§ 325(d) and 314(a).

patent

SAP America, Inc. et al. v.Valtrus Innovations Ltd.

· IPR2025-00418

SAP America seeks an IPR to invalidate Valtrus’s 6,871,264 patent covering a multi‑processor cache allocation system, arguing the claims are obvious over earlier patents. The petition also opposes discretionary denial under §§ 325(d) and 314(a).

patent

Koki Holdings America Ltd. et al. v.Kyocera Senco Industrial Tools, Inc.

· IPR2025-00263

Koki Holdings has filed an IPR petition challenging all 30 claims of Kyocera's 2022 gas‑spring fastener driving tool patent, asserting obviousness over several older nail‑gun patents and raising means‑plus‑function issues.

patent

SAVANT TECHNOLOGIES LLC d/b/a GE LIGHTING et al. v.Feit Electric Company, Inc.

· IPR2025-00260

Savant Technologies (GE Lighting) petitions the PTAB to invalidate claims 1 and 11‑14 of Feit Electric’s white‑light LED patent, arguing they are obvious over several LED‑related publications. The petition seeks institution of inter‑partes review.

patent

Micron Technology, Inc. et al. v.Yangtze Memory Technologies Company, Ltd.

· IPR2025-00191

Micron has filed an IPR petition challenging all 20 claims of YMTC’s 3D NAND patent, arguing obviousness over Nishikawa, Lu, and Nishikawa2 references and asserting no discretionary denial factors.

patent

Embody, Inc. et al. v.LifeNet Health

· IPR2025-00249

Embody and Zimmer Biomet have filed an IPR petition seeking cancellation of claims 1‑8 of LifeNet Health’s 11,318,227 patent covering electrospun collagen scaffolds. They argue obviousness and anticipation based on Huang2, Kuo, and Lee, and request institution of the review.

patent

Amazon.com, Inc. et al. v.NL Giken Inc.

· IPR2025-00250

Amazon has filed an IPR petition seeking cancellation of eight claims of NL Giken’s ’236 TV safety‑monitoring patent, alleging obviousness over several pre‑AIA references. The petition also argues that discretionary denial is unwarranted under the Fintiv framework.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →